Joost Kreijtz is CEO (Europe) of Trained Therapeutix Discovery, a biotech company with its R&D headquarters in the Netherlands. TTxD develops nanomedicines that target innate immunity at its source to unlock the full potential of immunotherapy in oncology and inflammatory diseases. Trained as a biomedical scientist with a focus on immunology, Joost brings over 15 years of drug development experience, specializing in translating immunotherapies from concept to clinic and building high-performing biotech teams and companies.